Table 1.
Description of nine acceptability indicators, combined to make the acceptability score.
Table 2.
Description of study locations.
Table 3.
Comparisons of demographic, infection and adverse event profiles of study participants across treatment groups.
Table 4.
Demographic characteristics by gender.
Table 5.
Breakdown of in-depth interview and focus group discussion participants for all five countries.
Fig 1.
Aggregate acceptability scores for all five countries included in the study.
Box plots include the mean (diamond), median (horizontal line), interquartile range (upper and lower edges of box), and whiskers (1.5 x IQR beyond upper or lower quartile). Scatter plots of the individual data points are overlaid with data randomly jittered to reduce overlap.
Table 6.
Results from univariable and multivariable linear mixed model analyses of the aggregate acceptability score outcome.
Table 7.
Feelings about number of pills.
Table 8.
Variables assessing survey participants’ understanding of the transmission, cause, and asymptomatic nature of LF across all five countries.